PNC Financial Services Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.6K | Buy |
|
|||||
|
2025
Q1 | $149K | Sell |
|
|||||
|
2024
Q4 | $352K | Buy |
|
|||||
|
2024
Q3 | $343K | Sell |
|
|||||
|
2024
Q2 | $502K | Buy |
|
|||||
|
2024
Q1 | $182K | Sell |
|
|||||
|
2023
Q4 | $153K | Sell |
|
|||||
|
2023
Q3 | $222K | Sell |
|
|||||
|
2023
Q2 | $326K | Sell |
|
|||||
|
2023
Q1 | $417K | Sell |
|
|||||
|
2022
Q4 | $430K | Sell |
|
|||||
|
2022
Q3 | $641K | Buy |
|
|||||
|
2022
Q2 | $416K | Sell |
|
|||||
|
2022
Q1 | $452K | Buy |
|
|||||
|
2021
Q4 | $180K | Buy |
|
|||||
|
2021
Q3 | $130K | Buy |
|
|||||
|
2021
Q2 | $79K | Buy |
|
|||||
|
2021
Q1 | $73K | Sell |
|
|||||
|
2020
Q4 | $248K | Buy |
|
|||||
|
2020
Q3 | $151K | Buy |
|
|||||
|
2020
Q2 | $77K | Sell |
|
|||||
|
2020
Q1 | $1.86M | Sell |
|
|||||
|
2019
Q4 | $2.51M | Sell |
|
|||||
|
2019
Q3 | $2.3M | Sell |
|
|||||
|
2019
Q2 | $6.17M | Sell |
|
|||||
|
2019
Q1 | $8.01M | Sell |
|
|||||
|
2018
Q4 | $8.8M | Sell |
|
|||||
|
2018
Q3 | $17M | Sell |
|
|||||
|
2018
Q2 | $14.5M | Sell |
|
|||||
|
2018
Q1 | $8.67M | Sell |
|
|||||
|
2017
Q4 | $7.47M | Sell |
|
|||||
|
2017
Q3 | $7.39M | Buy |
|
|||||
|
2017
Q2 | $618K | Buy |
|
|||||
|
2017
Q1 | $138K | Buy |
|
|||||
|
2016
Q4 | $51K | Sell |
|
|||||
|
2016
Q3 | $132K | Sell |
|
|||||
|
2016
Q2 | $123K | Sell |
|
|||||
|
2016
Q1 | $164K | Sell |
|
|||||
|
2015
Q4 | $438K | Buy |
|
|||||
|
2015
Q3 | $258K | Sell |
|
|||||
|
2015
Q2 | $256K | Buy |
|
|||||
|
2015
Q1 | $111K | Buy |
|
|||||
|
2014
Q4 | $108K | Sell |
|
|||||
|
2014
Q3 | $178K | Buy |
|
|||||
|
2014
Q2 | $232K | Buy |
|
|||||
|
2014
Q1 | $184K | Buy |
|
|||||
|
2013
Q4 | $146K | Sell |
|
|||||
|
2013
Q3 | $529K | Hold |
|
|||||
|
2013
Q2 | $426K | Buy |
|